Tiffany R. Farchione

Child and Adolescent Psychiatry

3811 Ohara St Rm 144
Pittsburgh, PA 15213

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Clinical trials of novel psychotropic agents: some caveats.

Clinical trials of novel psychotropic agents: some caveats.

Journal: World psychiatry : official journal of the World Psychiatric Association (WPA)

Published: October 25, 2022

Regulatory considerations in drug development for autism spectrum disorders.

Regulatory considerations in drug development for autism spectrum disorders.

Journal: European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology

Published: February 24, 2021

Drug development for Autism Spectrum Disorder (ASD): Progress, challenges, and future directions.

Drug development for Autism Spectrum Disorder (ASD): Progress, challenges, and future directions.

Journal: European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology

Published: January 25, 2021

Extrapolation of Efficacy and Dose Selection in Pediatrics: A Case Example of Atypical Antipsychotics in Adolescents With Schizophrenia and Bipolar I Disorder.

Extrapolation of Efficacy and Dose Selection in Pediatrics: A Case Example of Atypical Antipsychotics in Adolescents With Schizophrenia and Bipolar I Disorder.

Journal: Journal of clinical pharmacology

Published: December 29, 2020

Association of End Point Definition and Randomized Clinical Trial Duration in Clinical Trials of Schizophrenia Medications.

Association of End Point Definition and Randomized Clinical Trial Duration in Clinical Trials of Schizophrenia Medications.

Journal: JAMA psychiatry

Published: July 02, 2020

Shortened Positive and Negative Symptom Scale as an Alternate Clinical Endpoint for Acute Schizophrenia Trials: Analysis from the US Food & Drug Administration.

Shortened Positive and Negative Symptom Scale as an Alternate Clinical Endpoint for Acute Schizophrenia Trials: Analysis from the US Food & Drug Administration.

Journal: Psychiatric research and clinical practice

Published: January 03, 2020

Assessment of Similarity in Antipsychotic Exposure-Response Relationships in Clinical Trials Between Adults and Adolescents With Acute Exacerbation of Schizophrenia.

Assessment of Similarity in Antipsychotic Exposure-Response Relationships in Clinical Trials Between Adults and Adolescents With Acute Exacerbation of Schizophrenia.

Journal: Journal of clinical pharmacology

Published: November 20, 2019

The Trend of Increasing Placebo Response and Decreasing Treatment Effect in Schizophrenia Trials Continues: An Update From the US Food and Drug Administration.

The Trend of Increasing Placebo Response and Decreasing Treatment Effect in Schizophrenia Trials Continues: An Update From the US Food and Drug Administration.

Journal: The Journal of clinical psychiatry

Published: June 16, 2019

Esketamine for Treatment-Resistant Depression - First FDA-Approved Antidepressant in a New Class.

Esketamine for Treatment-Resistant Depression - First FDA-Approved Antidepressant in a New Class.

Journal: The New England journal of medicine

Published: May 23, 2019

Re: "Dasotraline in Children with Attention-Deficit/Hyperactivity Disorder: A Six-Week, Placebo-Controlled, Fixed-Dose Trial" by Findling et al. (J Child Adolesc Psychopharmacol 2019;29:80-89).

Re: "Dasotraline in Children with Attention-Deficit/Hyperactivity Disorder: A Six-Week, Placebo-Controlled, Fixed-Dose Trial" by Findling et al. (J Child Adolesc Psychopharmacol 2019;29:80-89).

Journal: Journal of child and adolescent psychopharmacology

Published: May 17, 2019

Challenges in Research on Suicide Prevention.

Challenges in Research on Suicide Prevention.

Journal: JAMA

Published: March 16, 2019

A Quantitative Justification of Similarity in Placebo Response Between Adults and Adolescents With Acute Exacerbation of Schizophrenia in Clinical Trials.

A Quantitative Justification of Similarity in Placebo Response Between Adults and Adolescents With Acute Exacerbation of Schizophrenia in Clinical Trials.

Journal: Clinical pharmacology and therapeutics

Published: January 07, 2019

Showing 1-12 of 17

Last Updated: 09/26/2026